Silencing heme oxygenase-1 increases the sensitivity of ABC-DLBCL cells to histone deacetylase inhibitor in vitro and in vivo

Heme oxygenase-1 (HO-1) can promote tumor growth and reinforce the resistance of diffuse large B-cell lymphoma (DLBCL) cells to chemotherapeutic drug vincristine. We herein found that HO-1 protein expression was higher in high-risk DLBCL patients than in low-risk ones. Silencing HO-1 gene expression...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhou, Zhen, Fang, Qin, Ma, Dan, Zhe, Nana, Ren, Mei, Cheng, Bingqing, Li, Peifan, Liu, Ping, Lin, Xiaojing, Tang, Sishi, Hu, Xiuying, Liao, Yudan, Zhang, Yaming, Lu, Tingting, Wang, Jishi
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5667976/
https://ncbi.nlm.nih.gov/pubmed/29108243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19652
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados